New JerseyState Snapshot for Prevention

In this comparison, the NHQDR measures for New Jersey for the most recent data year and the baseline year are compared to the average of all States.

Due to changes in methodology, including a transition from International Classification of Diseases, Ninth Revision (ICD-9) to Tenth Revision (ICD-10) codes and updates to the Quality Indicators software, the current measure set does not contain AHRQ Quality Indicator measure results based on Healthcare Cost and Utilization Project (HCUP) data. These changes to the measure set had a significant impact on overall meter scores, so they are not provided at this time. When data become available, State scores will again be included.

Measures Better Than Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adults who received a blood cholesterol measurement in the last 5 years 2017 90.0 Better than Average 2013 79.0 Better than Average
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine 2017 94.3 Better than Average 2008 64.3 Better than Average
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine 2017 92.0 Better than Average 2008 55.4 Better than Average
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 2017 94.0 Better than Average 2008 36.6 Average
Long-stay nursing home patients who were assessed and appropriately given the seasonal influenza vaccine 2017 94.8 Better than Average 2013 93.1 Better than Average
Long-stay nursing home residents who were assessed for pneumococcal vaccination 2017 94.9 Better than Average 2013 95.5 Better than Average
Short-stay nursing home patients who had flu vaccination appropriately given 2017 92.9 Better than Average 2013 89.4 Better than Average
Short-stay nursing home residents who were assessed for pneumococcal vaccination 2017 91.7 Better than Average 2013 89.7 Better than Average
Home health patients who had influenza vaccination during flu season 2017 96.9 Better than Average 2013 71.1 Worse than Average
Measures That Are Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adults ages 18-64 at high risk (e.g., COPD) who received an influenza vaccination in the last flu season 2017 41.8 Average 2013 35.4 Average
Adults age 65 and over who received an influenza vaccination in the last flu season 2017 63.8 Average 2013 57.5 Worse than Average
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine 2017 82.8 Average 2000 82.1 Average
Children ages 19-35 months who received 3 or more doses of polio vaccine 2017 92.5 Average 2000 87.7 Average
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine 2017 89.0 Average 2000 88.5 Average
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine 2017 91.2 Average 2000 89.1 Average
Children ages 19-35 months who received 1 or more doses of varicella vaccine 2017 90.8 Average 2000 67.8 Average
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 2017 87.0 Average 2008 47.7 Average
Women ages 50-74 who received a mammogram in the last 2 years 2016 80.4 Average 2014 78.4 Average
Breast cancer diagnosed at advanced stage (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over 2016 89.4 Average 2004 102.7 Worse than Average
Women ages 21-65 who received a Pap smear in the last 3 years 2016 81.9 Average 2014 83.7 Average
Cervical cancer diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 2016 10.4 Average 2004 13.4 Worse than Average
Measures Worse Than Average in The Recent Year
Measure Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adults ages 18-64 at high risk (e.g., COPD) who ever received pneumococcal vaccination 2017 33.6 Worse than Average 2013 30.5 Worse than Average
Adults age 65 and over who ever received pneumococcal vaccination 2017 72.2 Worse than Average 2013 62.4 Worse than Average
Home health patients who had pneumococcal polysaccharide vaccination 2017 83.1 Worse than Average 2015 81.2 Worse than Average
Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional or distant stage) per 100,000 population age 50 and over 2016 73.4 Worse than Average 2004 95.6 Worse than Average